Feature Channels: Vaccines

Filters close
Released: 26-Mar-2024 3:05 PM EDT
Flu-Vaccine Education in the Emergency Department Helps People get their Shot
Thomas Jefferson University

Patient education about flu shot during a non-life threatening emergency department visit increases vaccination rates, especially in patients without regular primary care.

Released: 26-Mar-2024 9:00 AM EDT
ReportLinker Reveals Key Insights About Players and Coverage in Latest Combination Vaccine Market Analysis
ReportLinker

Reportlinker announces the release of the report "A White Paper To Understand The Market Structure Of Pediatric Pertussis Hexavalent and Combination Vaccines".

18-Mar-2024 9:00 AM EDT
Researchers uncover key biomolecule involved in whooping cough infection
American Society for Biochemistry and Molecular Biology (ASBMB)

Researchers have identified a new complex-carbohydrate biomolecule, or glycan, that plays a key role in the nasal colonization of the Bordetella bacteria responsible for whooping cough. The discovery could make it possible to create a new drug or vaccine that interferes with the glycan to greatly reduce or even stop ongoing Bordetella transmission.

Not for public release

This news release is embargoed until 25-Mar-2024 5:00 PM EDT Released to reporters: 19-Mar-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 25-Mar-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: New vaccine against a highly fatal tropical disease – and potential bioterror weapon – demonstrates efficacy in animal studies
Released: 21-Mar-2024 3:05 PM EDT
New vaccine against a highly fatal tropical disease – and potential bioterror weapon – demonstrates efficacy in animal studies
University of California, Los Angeles (UCLA), Health Sciences

A vaccine against the bacterium that causes melioidosis was highly protective against the disease, which is endemic in many tropical areas, causing approximately 165,000 cases with 89,000 fatalities around the world each year. It is so dangerous that it is categorized as a Tier 1 Select Agent of bioterrorism.

Released: 21-Mar-2024 10:05 AM EDT
Michigan is seeing a rise in measles: MSU experts can comment on related health issues
Michigan State University

Earlier this week, the Centers for Disease Control and Prevention, or CDC, issued an advisory to inform clinicians and public health officials of an increase in global and U.S. measles cases.

Released: 19-Mar-2024 1:40 PM EDT
New Study Reveals Insights into Lack of Durability in COVID Antibody Response to Infections and Vaccines
University of Maryland School of Medicine

Researchers at the Institute of Human Virology (IHV) at the University of Maryland School of Medicine published a new study in the Journal of Infectious Diseases investigating the short-lived antibody response following SARS-CoV-2, the virus that causes COVID.

Not for public release

This news release is embargoed until 18-Mar-2024 5:00 PM EDT Released to reporters: 12-Mar-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 18-Mar-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 18-Mar-2024 3:05 PM EDT
Text nudges can increase uptake of COVID-19 boosters– if they play up a sense of ownership of the vaccine
University of California, Los Angeles (UCLA), Health Sciences

Text nudges encouraging people to get the COVID-19 vaccine, which had proven effective in prior real-world field tests, are also effective at prompting people to get a booster. The key in both cases is to include in the text a sense of ownership in the dose awaiting them.

Released: 18-Mar-2024 11:05 AM EDT
Don’t Delay Vaccines—They Are Safe, Effective and Save Lives
Children's Hospital Los Angeles

Vaccine misinformation has gone mainstream—a post-pandemic reality that is putting more children at risk of exposure to potentially serious vaccine-preventable diseases like measles.

Newswise: Vac to the future
Released: 14-Mar-2024 3:05 PM EDT
Vac to the future
La Jolla Institute for Immunology

“We are hoping to use this competition not just as a way to examine the capacity of people to predict vaccination outcomes, but also as a way to address an important public health question,” says Peters.

Released: 14-Mar-2024 11:05 AM EDT
Measles 2024: What You Need to Know
RUSH

Measles cases are being reported in different parts of the United States. David Nguyen, MD, a RUSH infectious disease physician who treats adults and children, answers the most common questions about the measles virus.

Not for public release

This news release is embargoed until 14-Mar-2024 11:05 AM EDT Released to reporters: 14-Mar-2024 11:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 14-Mar-2024 11:05 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 14-Mar-2024 9:10 AM EDT
Calder Biosciences Inc. Publishes Next-Generation Vaccine Technology in Nature Communications
Calder Biosciences Inc.

Calder Biosciences, Inc., a next-generation vaccine company, has been published in a Nature Communications article that debuts and validates the application of Calder's '3D Vaxlock' platform technology.

Released: 13-Mar-2024 10:05 AM EDT
How Rutgers Health Mobilized to Fight Covid-19
Rutgers University-New Brunswick

Multiple schools made significant discoveries and provided much-needed care to New Jersey’s disparate communities.

Released: 6-Mar-2024 9:05 AM EST
Four years later, what do we know about COVID-19?
Michigan Medicine - University of Michigan

Four years ago, a brand new virus turned the world upside down. Today, we know more and can do more about the coronavirus called SARS-CoV2, and the disease called COVID-19, than ever before. A summary of the latest knowledge and guidance.

Released: 4-Mar-2024 4:05 PM EST
Breastfeeding after COVID-19 booster can give babies antibodies
University of Florida

A recently published study that shows lactating mothers who get the COVID-19 booster pass along the antibodies to their children via their breast milk – and potentially protect babies too young to receive the vaccine.

   


close
2.7176